A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer

被引:2
|
作者
Wang, Guancong [1 ]
Li, Jiasen [2 ]
Huang, Ying [3 ]
Guo, Yincong [1 ]
机构
[1] Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Colorectal & Anal Surg, Zhangzhou 363000, Peoples R China
[2] Fujian Med Univ, ZhangZhou Affiliated Hosp, Dept Intervent Radiol, Zhangzhou, Peoples R China
[3] Fujian Med Univ, Dept Colorectal Surg, Union Hosp, Fuzhou 350001, Peoples R China
来源
CANCER MEDICINE | 2024年 / 13卷 / 11期
关键词
dynamic nomogram; locally advanced rectal cancer; neoadjuvant chemoradiotherapy; pathological complete response; total mesorectal excision; MUCINOUS ADENOCARCINOMA; TUMOR RESPONSE; ANAL VERGE; CHEMORADIOTHERAPY; THERAPY; RADIOTHERAPY; PROGNOSIS; DISTANCE; MRI;
D O I
10.1002/cam4.7251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To explore the clinical factors associated with pathologic complete response (pCR) for locally advanced rectal cancer (LARC) patients treated with neoadjuvant chemoradiotherapy (nCRT) and develop a web-based dynamic nomogram. Methods: Retrospective analysis of patients with examination confirmed LARC from 2011 to 2022. Patients from the Union Hospital of Fujian Medical University were included as the training cohort (n = 1579) and Zhangzhou Hospital of Fujian Medical University as the external validation cohort (n = 246). Results: In the training cohort, after nCRT, 350 (22.2%) patients achieved pCR. More stomas were avoided in pCR patients (73.9% vs. 69.7%, p = 0.043). After a median follow-up time of 47.7 months (IQR 2-145) shown OS (5-year: 93.7% vs. 81.0%, HR = 0.310, 95%CI: 0.189-0.510, p < 0.001) and DFS (5-year: 91.2% vs. 75.0%, HR = 0.204, 95%CI: 0.216-0.484, p < 0.001) were significantly better among patients with pCR than non-pCR. Multivariable Logistic analysis shown pCR was significantly associated with Pre-CRT CEA (HR = 0.944, 95%CI: 0.921-0.968; p < 0.001), histopathology (HR = 4.608, 95%CI: 2.625-8.089; p < 0.001), Pre-CRT T stage (HR = 0.793, 95%CI: 0.634-0.993; p = 0.043), Pre-CRT N stage (HR = 0.727, 95%CI: 0.606-0.873; p = 0.001), Pre-CRT MRI EMVI (HR = 0.352, 95%CI: 0.262-0.473; p < 0.001), total neoadjuvant therapy (HR = 2.264, 95%CI: 1.280-4.004; p = 0.005). Meanwhile, the online version of the nomogram established in this study was publicized on an open-access website (URL: ). The model predicted accuracy with a C-index of 0.73 (95% CI: 0.70-0.75), with an average C-index of 0.73 for the internal cross validation and 0.78 (95% CI: 0.72-0.83) for the external validation cohort, showing excellent model accuracy. Delong test results showed the model has an important gain value for clinical characteristics to predict pCR in rectal cancer. Conclusions: Patients with pCR had a better prognosis, including OS and DFS, and were independently associated with Pre-CRT CEA, histopathology, Pre-CRT T/N stage, Pre-CRT MRI EMVI, and TNT. A web-based dynamic nomogram was successfully established for clinical use at any time.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer
    Gollub, M. J.
    Gultekin, D. H.
    Akin, O.
    Do, R. K.
    Fuqua, J. L., III
    Gonen, M.
    Kuk, D.
    Weiser, M.
    Saltz, L.
    Schrag, D.
    Goodman, K.
    Paty, P.
    Guillem, J.
    Nash, G. M.
    Temple, L.
    Shia, J.
    Schwartz, L. H.
    EUROPEAN RADIOLOGY, 2012, 22 (04) : 821 - 831
  • [22] Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer
    M. J. Gollub
    D. H. Gultekin
    O. Akin
    R. K. Do
    J. L. Fuqua
    M. Gonen
    D. Kuk
    M. Weiser
    L. Saltz
    D. Schrag
    K. Goodman
    P. Paty
    J. Guillem
    G. M. Nash
    L. Temple
    J. Shia
    L. H. Schwartz
    European Radiology, 2012, 22 : 821 - 831
  • [23] Role of clinical variables for predicting pathologic response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Taglietti, Paula Mendonca
    Aguiar, Samuel
    Amor Divino, Paulo Henrique
    Begnami, Maria D.
    Sobreira Batista, Ranyell Spencer
    Mello, Celso Lopes
    Lopes, Ademar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Positron emission tomography for predicting pathologic response following neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    Chennupati, S. K.
    Welton, M.
    Shelton, A.
    Fisher, G. A.
    Ford, J. M.
    Pai, R. K.
    Quon, A.
    Kamaya, A.
    Koong, A. C.
    Chang, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S268 - S269
  • [25] Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
    Chennupati, Sravana K.
    Quon, Andrew
    Kamaya, Aya
    Pai, Reetesh K.
    La, Trang
    Krakow, Trevor E.
    Graves, Edward
    Koong, Albert C.
    Chang, Daniel T.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (04): : 334 - 339
  • [26] Predicting pathologic response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using FDG PET/CT
    Shanmugan, S.
    Arrangoiz, R.
    Nitzkorski, J. R.
    Yu, J. Q.
    Li, T.
    Konski, A. A.
    Farma, J. M.
    Sigurdson, E. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [27] Genomic profiling of pathologic complete response in locally advanced rectal cancer
    Bedrosian, Isabelle
    Hao, Qiang
    Ding, L.
    Rodriguez-Bigas, Miguel
    Skibber, John M.
    Chang, George J.
    Story, Michael D.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S50 - S51
  • [28] Neoadjuvant chemotherapy for locally advanced rectal cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (10): : 876 - 876
  • [29] Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
    Papaccio, Federica
    Rosello, Susana
    Huerta, Marisol
    Gambardella, Valentina
    Tarazona, Noelia
    Fleitas, Tania
    Roda, Desamparados
    Cervantes, Andres
    CANCERS, 2020, 12 (12) : 1 - 12
  • [30] Predicting pathologic complete response in locally advanced rectal cancer patients after neoadjuvant therapy: a machine learning model using XGBoost
    Xijie Chen
    Wenhui Wang
    Junguo Chen
    Liang Xu
    Xiaosheng He
    Ping Lan
    Jiancong Hu
    Lei Lian
    International Journal of Colorectal Disease, 2022, 37 : 1621 - 1634